Depression as a predictor of disease progression and mortality in cancer patients: A meta-analysis

Cancer

Volumn 115, Issue 22, 2009, Pages 5349-5361

  Satin, Jillian R ^a   Linden, Wolfgang ^a   Phillips, Melanie J ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Cancer; Depression; Meta analysis; Mortality; Psychosocial oncology; Recurrence

Indexed keywords

ARTICLE; CANCER GROWTH; CANCER MORTALITY; CANCER PATIENT; CANCER RISK; CLINICAL FEATURE; DEPRESSION; DISEASE COURSE; HUMAN; MAJOR DEPRESSION; PRIORITY JOURNAL; PROGNOSIS; PUBLISHING; SYSTEMATIC REVIEW;

ADULT; AGED; DEPRESSION; DEPRESSIVE DISORDER; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; RECURRENCE; RISK;

EID: 70449369312     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24561     Document Type: Article

References (86)

1. Levin T, Kissane DW. Psychooncology: the state of its development in 2006. Eur J Psychiat. 2006;20:183-197.
2. Lemon J, Edelman S, Kidman AD. Perceptions of the "Mind-Cancer" relationship by members of the public, cancer patients and oncologists. J Psychosoc Oncol. 2004;21:43-58.
3. van't Spijker A, Trijsburg RW, Duivenvoorden HJ. Psychological sequelae of cancer diagnosis: a meta-analytical review of 58 studies after 1980. Psychosom Med. 1996;59:280-293.
4. Thaker PM, Han LY, Kamat AA, et al. Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nature Med. 2006;12:939-944.
5. Ben-Eliyahu S, Page GG, Yirmiya R, Shakhar G. Evidence that stress and surgical interventions promote tumor development by suppressing natural killer cell activity. Int J Cancer. 1999;80:880-888. (Pubitemid 29108864)
6. Palermo-Neto J, de Oliviera Massoco C, Robespierre de Souza W. Effects of physical and psychological stressors on behavior, macrophage activity, and Ehrlich tumor growth. Brain Behav Immun. 2003;17:43-54. (Pubitemid 36207601)
7. Saul AN, Oberyszyn TM, Daugherty C, et al. Chronic stress and susceptibility to skin cancer. J Natl Cancer Instit. 2005;97:1760-1767. (Pubitemid 41782285)
8. Reiche EMV, Nunes SOV, Morimoto HK. Stress, depression, the immune system, and cancer. Lancet Oncol. 2004;5:617-625. (Pubitemid 39303129)
9. Seruga B, Zhang H, Bernstein LJ, Tannock IF. Cytokines and their relationship to the symptoms and outcome of cancer. Nat Rev Cancer. 2008;8:887-899.
10. Shekelle RB, Raynor WJ Jr, Ostfeld AM. Psychological depression and 17-year risk of death from cancer. Psychosom Med. 1981;43:117-125.
11. Zonderman AB, Costa P Jr, McCrae RR. Depression as a risk for cancer morbidity and mortality in a nationally representative sample. JAMA. 1989;262:1191-1195.
12. Kaplan GA, Reynolds P. Depression and cancer mortality and morbidity: prospective evidence from the Alameda County study. J Behav Med. 1988;11:1-13. (Pubitemid 18121684)
13. Spiegel D, Bloom JR, Kraemer HC, Gottheil E. Effect of psychosocial treatment on survival of patients with metastatic breast cancer. Lancet. 1989;2:888-891. (Pubitemid 19245291)
14. Edelman S, Lemon J, Bell DR, et al. Effects of group CBT on the survival time of patients with metastatic breast cancer. Psychooncology. 1999;8:474-481. (Pubitemid 30014680)
15. Edmonds CV, Lockwood GA, Cunningham AJ. Psychological response to long-term therapy: a randomized trial with metastatic breast cancer patients. Psychooncology. 1999;8:74-91. (Pubitemid 29116268)
16. Cunningham AJ, Edmonds CV, Jenkins GP, Pollack H, Lockwood GA, Warr D. A randomized controlled trial of the effects of group psychological therapy on survival in women with metastatic breast cancer. Psychooncology. 1998;7:508-517. (Pubitemid 29012723)
17. Goodwin PJ, Leszcz M, Ennis M, et al. The effect of group psychosocial support on survival in metastatic breast cancer. N Engl J Med. 2001;345:1719-1726.
18. Kissane DW, Love A, Hatton A, et al. The effect of cognitive- existential group therapy on survival in early stage breast cancer. J Clin Oncol. 2004;2:4255-4260.
19. Coyne JC, Stefanek M, Palmer SC. Psychotherapy and survival in cancer: the conflict between hope and evidence. Psych Bull. 2007;133:367-394.
20. Chow E, Tsao MN, Harth T. Does psychosocial intervention improve survival in cancer? A meta-analysis. Palliat Med. 2004;18:25-31.
21. Edwards AG, Hailey S, Maxwell M. Psychological interventions for women with metastatic breast cancer. Cochrane Database Syst Rev. 2004;2:CD004253.
22. Meyer TJ, Mark MM. Effects of psychosocial interventions with adult cancer patients: a meta-analysis of randomized experiments. Health Psych. 1995;14:101-108.
23. Smedslund G, Ringdal GI. Meta-analysis of the effects of psychosocial interventions on survival time in cancer patients. J Psychosom Res. 2004;57:123-131.
24. Milo KM. The relationship between depression and cancer survival. Med Health. 2003;86:249-250.
25. Spiegel D, Giese-Davis J. Depression and cancer: mechanisms and disease progression. Biol Psych. 2003;54:269-282.
26. De Boer MF, Ryckman RM, Pruyn JF, Van den Borne HW. Psychosocial correlates of cancer relapse and survival: a literature review. Patient Educ Couns. 1999;37:215-230.
27. Reich M. Depression and cancer: recent data on clinical issues, research challenges and treatment approaches. Curr Opin Oncol. 2008;20:353-359.
28. Hilakivi-Clarke L, Rowland J, Clarke R, Lippman ME. Psychosocial factors in the development and progression of breast cancer. Breast Cancer Res Treat. 1994;29:141-160.
29. McGee R, Williams S, Elwood M. Depression and the development of cancer: a meta-analysis. Soc Sci Med. 1994;38:187-192.
30. Andrykowski MA, Brady MJ, Henslee-Downey PJ. Psychosocial factors predictive of survival after allogeneic bone marrow transplantation for leukemia. Psychosom Med. 1994;56:432-439.
31. Barraclough J, Pinder P, Cruddas M, Osmond C, Taylor I, Perry M. Life events and breast cancer prognosis. BMJ. 1992;304:1078-1081.
32. Beresford TP, Alfers J, Mangum L, Clapp L, Martin B. Cancer survival probability as a function of ego defense (adaptive) mechanisms versus depressive symptoms. Psychosomatics. 2006;47:247-253.
33. Bergenmar M, Nilsso B, Hansson J, Brandberg Y. Anxiety and depressive symptoms measured by the Hospital Anxiety and Depression Scale as predictors of time to recurrence in localized cutaneous melanoma. Acta Oncol. 2004;43:161-168.
34. Broers S, Hengeveld MW, Kaptein AA, Le Cessie S, van de Loo F, de Vries T. Are pretransplant psychological variables related to survival after bone marrow transplantation? A prospective study of 123 consecutive patients. Journal Psychosom Res. 1998;45:341-351.
35. Brown KW, Levy AR, Rosberger Z, Edgar L. Psychological distress and cancer survival: a follow-up 10 years after diagnosis. Psychosom Med. 2003;65:636-643.
36. Buccheri G. Depressive reactions to lung cancer are common and often followed by a poor outcome. Eur Respir J. 1998;11:173-178.
37. Chang G, Orav EJ, McNamara T, Tong M-Y, Antin JH. Depression, cigarette smoking, and hematopoietic stem cell transplantation outcome. Cancer. 2004;101:782-789.
38. Faller H, Schmidt M. Prognostic value of depressive coping and depression in survival of lung cancer patients. Psychooncology. 2004;13:359-363.
39. Graham J, Ramirez A, Love S, et al. Stressful life experiences and risk of relapse of breast cancer. BMJ. 2002;324:1420.
40. Gripp S, Moeller S, Bolke E, et al. Survival prediction in terminally ill cancer patients by clinical estimates, laboratory tests, and self-rated anxiety and depression. J Clin Oncol. 2007;25:3313-3320.
41. Groenvold M, Peterson MA, Idler E, Bjorner JB, Fayers PM, Mouridsen HT. Psychological distress and fatigue predicted recurrence and survival in primary breast cancer patients. Breast Cancer Res Treat. 2007;105:209-219.
42. Grulke N, Larbig W, Kachele H, Bailer H. Pre-transplant depression as risk factor for survival of patients undergoing allogenic haematopoietic stem cell transplantation. Psychooncology. 2008;17:480-487.
43. Lam PT, Leung MW, Tse CY. Identifying prognostic factors for survival in advanced cancer patients: a prospective study. Hong Kong Med J. 2007;13:453-459.
44. Lehto US, Ojanen M, Dyba T, et al. Baseline psychosocial predictors of survival in localized melanoma. J Psychosom Res. 2007;63:9-15.
45. Lloyd-Williams M, Shiels C, Taylor F, Dennis M. Depression - an independent predictor of early death in patients with advanced cancer. J Affect Disord. 2009;113:127-132.
46. Mainio A, Tuunanen S, Hakko H, Niemela A, Kolvukangas J, Rasanen P. Decreased quality of life and depression as predictors for shorter survival among patients with lowgrade gliomas: a follow-up from 1990 to 2003. Eur Arch Psychiatry Clin Neurosci. 2006;256:516-521.
47. Murphy KC, Jenkins PL, Whittaker JA. Psychosocial morbidity and survival in adult bone marrow transplant recipients: a follow-up study. Bone Marrow Transplant. 1996;18:199-201.
48. Nakaya N, Saito-Nakaya K, Akizuki N, et al. Depression and survival in patients with non-small cell lung cancer after curative resection: a preliminary study. Cancer Sci. 2006;97:199-205.
49. Nakaya N, Saito-Nakaya K, Akechi T, et al. Negative psychological aspects and survival in lung cancer patients. Psychooncology. 2008;17:466-473.
50. Onitilo AA, Nietert PJ, Egede LE. Effect of depression on all-cause mortality in adults with cancer and differential effects by cancer site. Gen Hosp Psychiatry. 2006;28:396-402.
51. Osborne RH, Sali A, Aaronson NK, Elsworth GR, Mdzewski B, Sinclair AJ. Immune function and adjustment style: do they predict survival in breast cancer? Psychooncology. 2004;3:199-210.
52. Phillips K-A, Osborne RH, Giles GG, et al. Psychosocial factors and survival of young women with breast cancer: a population-based prospective cohort study. J Clin Oncol. 2008;26:4666-4671.
53. Pirl WF, Temel JS, Billings A, et al. Depression after diagnosis of advanced non-small cell lung cancer and survival: a pilot study. Psychosomatics. 2008;49:218-224. (Pubitemid 351668723)
54. Prieto JM, Atala J, Blanch J, et al. Role of depression as a predictor of mortality among cancer patients after stem-cell transplantation. J Clin Oncol. 2005;23:6063-6071. (Pubitemid 46300224)
55. Richardson JL, Zarnegar Z, Bisno B, Levine A. Psychosocial status at initiation of cancer treatment and survival. J Psychosom Res. 1990;34:189-201. (Pubitemid 20154311)
56. Ringdal GI, Gotestam KG, Kaasa S, Kvinnsland S, Ringdal K. Prognostic factors and survival in a heterogeneous sample of cancer patients. Br J Cancer. 1996;73:1594-1599. (Pubitemid 26235390)
57. Saito-Nakaya K, Nakaya N, Akechi T, et al. Marital status and non-small cell lung cancer survival: the lung cancer database project in Japan. Psychooncology. 2008;17:869-876.
58. Steel JL, Geller DA, Gamblin TC, Olek MC, Carr BI. Depression, immunity, and survival in patients with hepatobiliary carcinoma. J Clin Oncol. 2007;25:2397-2405. (Pubitemid 46999210)
59. Stommel M, Given BA, Given CW. Depression and functional status as predictors of death among cancer patients. Cancer. 2002;94:2719-2727. (Pubitemid 34478089)
60. Watson M, Homewood J, Haviland J, Bliss JM. Influence of psychological response on breast cancer survival: 10-year follow-up of a population-based cohort. Eur J Cancer. 2005;41:1710-1714. (Pubitemid 41132630)
61. Borenstein M, Hedges L, Higgins J, Rothstein H. Comprehensive Meta-Analysis. Version 2. Englewood, NJ: Biostat Inc; 2005.
62. Stroup DF, Berlin JF, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA. 2000;283:2008-2012.
63. Borenstein M. A Short Course in Meta-Analysis [e-book]. 2005. Available at: http://www.Meta-Analysis.com Accessed on May 7, 2007.
64. Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;2:1539-1558.
65. Barth J, Schumacher M, Hermann-Lingen C. Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis. Psychosom Med. 2004;66:802-813. (Pubitemid 39552862)
66. de Graeff A, de Leeuw JRJ, Ros WJG, Hordijk GJ, Blijham GH, Winnubst JAM. Sociodemographic factors and quality of life as prognostic indicators in head and neck cancer. Eur J Cancer. 2001;37:332-339. (Pubitemid 32182321)
67. Derogatis LR, Abeloff MD, Melisaratos N. Psychological coping mechanisms and survival time in metastatic breast cancer. JAMA. 1979;242:1504-1508. (Pubitemid 10243607)
68. Edwards J, DiClemente G, Samuels, ML. Psychological characteristics: a pretreatment survival marker of patients with testicular cancer. Psychosoc Oncol. 1985;3:79-94. (Pubitemid 15023798)
69. Faller H, Bulzebruck H, Drings P, Lang H. Coping, distress, and survival among patients with lung cancer. Arch Gen Psychiatry. 1999;56:756-762. (Pubitemid 29357738)
70. Gilbar O. The connection between the psychological condition of breast cancer patients and survival: a follow-up after 8 years. Gen Hosp Psychiatry. 1996;18:266-270. (Pubitemid 26251514)
71. Jamison RN, Burish TG, Wallston KA. Psychogenic factors in predicting survival of breast cancer patients. J Clin Oncol. 1987;5:768-772. (Pubitemid 17120254)
72. Lehto U-S, Ojanen M, Dyba T, Aromaa A, Kellokumpu-Lehtinen P. Baseline psychosocial predictors of survival in localized breast cancer. Br J Cancer. 2006;94:1245-1252.
73. Leigh H, Percarpio B, Opsahl C, Ungerer J. Psychological predictors of survival in cancer patients undergoing radiation therapy. Psychother Psychosom. 1987;47:65-73. (Pubitemid 18079939)
74. Meyer HAM, Sinnott C, Seed PT. Depressive symptoms in advanced cancer. Part 2. Depression over time; the role of the palliative care professional. Palliat Med. 2003;17:604-607.
75. Morris T, Pettingale K, Haybittle J. Psychological response to cancer diagnosis and disease outcome in patients with breast cancer and lymphoma. Psychooncology. 1992;1:105-114.
76. Naughton MJ, Herndon JE, Shumaker SA, et al. The health-related quality of life and survival of small-cell lung cancer patients: results of a companion study to CALGB 9033. Qual Life Res. 2002;11:235-248.
77. Palmer JL, Fisch MJ. Association between symptom distress and survival in outpatients seen in a palliative care cancer center. J Pain Symptom Manage. 2005;29:565-571.
78. Pamuk GE, Harmandar F, Ermantas N, et al. EORTC QLQ-C30 assessment in Turkish patients with hematological malignancies: association with anxiety and depression. Ann Hematol. 2008;87:305-310.
79. Schulz R, Bookwala J, Knapp JE, Scheier M, Williamson GM. Pessimism, age, and cancer mortality. Psychol Aging. 1996;11:304-309.
80. Viganó A, Bruera E, Jhangri GS, Newman SC, Fields AL, Suarez-Almazor ME. Clinical survival predictors in patients with advanced cancer. Arch Intern Med. 2000;160:861-868. (Pubitemid 30165248)
81. Aass N, Fossa SD, Dahl AA, Moe TJ. Prevalence of anxiety and depression in cancer patients seen at the Norwegian Radium Hospital. Eur J Cancer. 1997;33:1597-1604. (Pubitemid 28123481)
82. Cuijpers P, Smit F. Excess mortality in depression: a meta-analysis of community studies. J Affect Disord. 2002;72:227-236. (Pubitemid 35351282)
83. Segerstrom SC, Miller GE. Psychological stress and the human immune system: a meta-analytic study of 30 years of inquiry. Psych Bull. 2004;130:601-630.
84. Levy SM, Roberts DC. Clinical Significance of Psychoneuroimmunulogy: Prediction of Cancer Outcomes. In: Schneiderman N, McCabe P, Baum A, eds. Perspectives in Behavioral Medicine: Stress and Disease Processes. Hillsdale, NJ: Lawrence Erlbaum Associates; 1992:165-174.
85. Gotay CC, Kawamoto CT, Bottomley A, Efficace F. The prognostic significance of patient-reported outcomes in cancer clinical trials. J Clin Oncol. 2008;26:1355-1363.
86. Linden W, Satin JR. Avoidable pitfalls in behavioural medicine outcome research. Ann Behav Med. 2007;33:143-147. (Pubitemid 47289492)